ADME/DMPK in the Development and Use of Tyrosine and Serine-Threonine Kinase Inhibitors

ADMET and DMPK - Croatia
doi 10.5599/admet.4.3.348
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Association of Physical Chemists (IAPC)

Related search

Altered Serine/Threonine Kinase Activity in Schizophrenia

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2014English

Deoxythymidylate Kinase (DTYMK); Serine/Threonine Kinase 11 (STK11; LKB1)

Science-Business eXchange
2013English

Evidence That Pp42, a Major Tyrosine Kinase Target Protein, Is a Mitogen-Activated Serine/Threonine Protein Kinase.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Identification and Characterization of Novel Receptor Interacting Serine/Threonine‐Protein Kinase 2 (RIPK2) Inhibitors Using Structural Similarity Analysis

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2018English

Prevention of Pulmonary Vascular and Myocardial Remodeling by the Combined Tyrosine and Serine-/Threonine Kinase Inhibitor, Sorafenib, in Pulmonary Hypertension and Right Heart Failure

European Respiratory Review
PulmonaryRespiratory Medicine
2008English

New Test System for Serine/Threonine Protein Kinase Inhibitors Screening: E. Coli APHVIII/Pk25 Design.

Acta Naturae
BiochemistryBiotechnologyMolecular MedicineMolecular Biology
2010English

Receptor-Interacting Serine-Threonine Kinase 3 (RIPK3; RIP3)

Science-Business eXchange
2009English

Demonstration of Cyclin-Dependent Kinase Inhibitory Serine/Threonine Kinase in Bovine Thymus

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Novel Bruton's Tyrosine Kinase Inhibitors Currently in Development

OncoTargets and Therapy
OncologyPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy